How Treatment May Help


How Treatment May Help You

PROMACTA can boost low platelet counts with a once-daily tablet or oral suspension

PROMACTA® (eltrombopag) is a chronic ITP treatment that boosts platelets in a once-daily tablet or oral suspension. 


That means your child can take PROMACTA almost anywhere—at home, school, or on the go. It also means fewer needles and doctor’s visits!


PROMACTA is the only oral platelet booster approved for use in children. Doctors use PROMACTA when medications such as steroids and IVIg:

  • have not kept platelet levels up, or 
  • have caused too many side effects 


PROMACTA can be taken by itself or with other treatments.


In one trial, nearly half of the participating children were able to stop taking their other ITP treatments with PROMACTA. 

In clinical trials of children with ITP, PROMACTA boosted platelet levels and kept levels up over time.

PROMACTA® (eltrombopag) platelet response rates in children with chronic immune thrombocytopenia (ITP) over 12 weeks in the clinical trial PETIT2.


Source: Grainger JD, Locatelli F, Chotsampancharoen T, et al. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;386(10004):1649-1658.

*Response defined as achieving a platelet count greater than or equal to 50,000 per microliter of blood without rescue therapy.